PRoducing Outcome Measures for OTP Quality Improvement (NCT07214389)
Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On: Project 2 - Producing Outcome Measures for OTP Quality Improvement
๐ฉบ Plain-English Summary (8th-Grade Level)
This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care. Forty-five BayMark OTPs in multiple states will be randomly assigned to one of three groups: (1) quality measures + QI toolkit; (2) quality measures + QI toolkit + external QI facilitation; or (3) usual care. The primary outcome is 90-day retention in treatment, measured from OTP electronic health records and Medicaid claims. Secondary outcomes include emergency department visits, hospitalizations, overdoses, and mortality. Findings will identify practical, scalable strategies to improve patient retention in OTPs.
Who can join: Review the eligibility criteria below.
Location: RTI International โ Research Triangle Park, North Carolina
Age range: 18 Years
๐งช Interventions in This Study
- Quality Measures (Audit and Feedback) (BEHAVIORAL)
- Quality Improvement (QI) Toolkit (BEHAVIORAL)
- External QI Facilitation (BEHAVIORAL)
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- RTI International โ Research Triangle Park, North Carolina
๐ Contact the Study Coordinator
Phone: (301) 816-4612
Email: tmark@rti.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Opioid Use Disorder
- Therapy and Peer Support for Patients Taking Medication for Opioid Use Disorder โ Atlantic City, New Jersey
- The Emergency Department Longitudinal Integrated Care โ Seattle, Washington
- Virtual Reality Cognitive-Affective Training for Opioid Use Disorder- A Phase 2 RCT โ La Jolla, California
- Extended-release Buprenorphine as a Novel Low-dose Induction Strategy โ Boston, Massachusetts
- Healing Opioid Misuse and Pain Through Engagement (HOPE) Trial โ Ann Arbor, Michigan
- Telemedicine XR-B for Individuals in Jail โ Cumberland, Maryland
Explore by condition: All Opioid Use Disorder clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.